Search results
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
May 9, 2024 · Tasuku Honjo, Japanese immunologist who contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses and whose work led to the development of novel immunotherapies against cancer. Honjo received a share of the 2018 Nobel Prize for Physiology or Medicine.
- Kara Rogers
Oct 1, 2018 · 01 October 2018. Cancer immunologists scoop medicine Nobel prize. James Allison and Tasuku Honjo pioneered treatments that unleash the body’s own immune system to attack cancer cells. By. Heidi...
- Heidi Ledford, Holly Else, Matthew Warren
- 2018
Tasuku HONJO, Head of Department | Cited by 77,615 | of Kyoto University, Kyoto (Kyodai) | Read 544 publications | Contact Tasuku HONJO
Tasuku Honjo: For scientific career I think I made two major contributions. One is I found the molecular mechanism for the antibody diversity, namely antigen induced antibody diversity class switch recombination and somatic mutation and this PD-1 break discovery and its application to cancer immunotherapy.
Telephone interview with Tasuku Honjo following the announcement of the 2018 Nobel Prize in Physiology or Medicine on 1 October 2018. The interviewer is Adam Smith, Chief Scientific Officer of Nobel Media.
Jan 18, 2017 · The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation”.
